Table 1 Clinical and demographic characters for enrolled patients
From: Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
Factors | Breast cancer (n = 112) | Benign breast lesion (n = 41) | Control group (n = 25) |
|---|---|---|---|
Age (mean ± SEM) | 53 ± 0.8 | 50 ± 1.24 | 49 ± 1.6 |
 ≤ 50 years (n = 94) | 58 | 21 | 15 |
 > 50 years (n = 84) | 54 | 20 | 10 |
Menopausal status | |||
 Pre-menopause (n = 114) | 69 | 27 | 18 |
 Post-menopause (n = 64) | 43 | 14 | 7 |
Pathological type | |||
 DCIS | 46 |  |  |
 IDC | 66 |  |  |
Clinical stage | |||
 Early stage | 48 |  |  |
 Late stage | 64 |  |  |
Histological grade | |||
 Low grade | 42 |  |  |
 High grade | 70 |  |  |
Lymph node involvement | |||
 Negative | 60 |  |  |
 Positive | 52 |  |  |
ER status | |||
 Negative | 60 |  |  |
 Positive | 52 |  |  |
PgR status | |||
 Negative | 58 |  |  |
 Positive | 54 |  |  |
HER-2neu status | |||
 Negative | 40 |  |  |
 Positive | 72 |  |  |